ID   SCCF1
AC   CVCL_L419
DR   ABM; T8294
DR   Wikidata; Q54952376
RX   DOI=10.4236/ojvm.2012.24045;
RX   PubMed=11776973;
RX   PubMed=19754818;
RX   PubMed=22265717;
CC   Derived from site: In situ; Larynx; UBERON=UBERON_0001737.
DI   NCIt; C132824; Feline oral squamous cell carcinoma
OX   NCBI_TaxID=9685; ! Felis catus (Cat)
SX   Female
AG   Age unspecified
CA   Cancer cell line
DT   Created: 06-05-13; Last updated: 10-04-25; Version: 11
//
RX   DOI=10.4236/ojvm.2012.24045;
RA   Balkman C.E., Gieger T.L., Zgola M.M., Lewis L.D., McEntee M.C.;
RT   "In vitro characterization of docetaxel as a radiosensitizer in canine
RT   and feline cancer cell lines.";
RL   Open J. Vet. Med. 2:285-292(2012).
//
RX   PubMed=11776973; DOI=10.1290/1071-2690(2001)037<0676:FHANSC>2.0.CO;2;
RA   Tannehill-Gregg S.H., Kergosien E., Rosol T.J.;
RT   "Feline head and neck squamous cell carcinoma cell line:
RT   characterization, production of parathyroid hormone-related protein,
RT   and regulation by transforming growth factor-beta.";
RL   In Vitro Cell. Dev. Biol. Anim. 37:676-683(2001).
//
RX   PubMed=19754818; DOI=10.1111/j.1476-5810.2006.00096.x;
RA   Tannehill-Gregg S.H., Levine A.L., Rosol T.J.;
RT   "Feline head and neck squamous cell carcinoma: a natural model for the
RT   human disease and development of a mouse model.";
RL   Vet. Comp. Oncol. 4:84-97(2006).
//
RX   PubMed=22265717; DOI=10.1016/j.oraloncology.2011.12.012; PMCID=PMC3350825;
RA   Martin C.K., Dirksen W.P., Shu S.T., Werbeck J.L., Thudi N.K.,
RA   Yamaguchi M., Wolfe T.D., Heller K.N., Rosol T.J.;
RT   "Characterization of bone resorption in novel in vitro and in vivo
RT   models of oral squamous cell carcinoma.";
RL   Oral Oncol. 48:491-499(2012).
//